Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Keryx Biopharm Inc (KERX)

Keryx Biopharm Inc (KERX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Keryx Biopharm Inc ONE MARINA PARK DR. BOSTON MA 02210 USA

www.keryx.com P: 617-466-3500

Description:

Keryx Biophamaceutical, Inc. uses data discovered through the mapping of the human genome to generate drug candidates that target the regulation of protein kinases. Protein kinases play a key role in the way cells communicate.

Key Statistics

Overview:

Market Capitalization, $K 343,997
Shares Outstanding, K 102,380
Annual Sales, $ 60,640 K
Annual Net Income, $ -163,440 K
Last Quarter Sales, $ 28,040 K
Last Quarter Net Income, $ -17,000 K
60-Month Beta 2.35
% of Insider Shareholders 1.61%
% of Institutional Shareholders 69.00%

Growth:

1-Year Return -24.83%
3-Year Return -37.55%
5-Year Return -74.19%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth -144.44%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.26 on 02/07/18
Latest Earnings Date 02/06/19
Earnings Per Share ttm -0.75
EPS Growth vs. Prev Qtr 17.65%
EPS Growth vs. Prev Year 30.00%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

KERX Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % -60.05%
Profit Margin % -269.53%
Debt/Equity -8.87
Price/Sales 5.79
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -0.45
Interest Coverage 0.00
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar